BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$438.23M
↑ 224% above average
Average (9y)
$135.37M
Historical baseline
Range
High:$438.23M
Low:$16.14M
CAGR
+28.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $438.23M | +34.1% |
| 2023 | $326.75M | +23.7% |
| 2022 | $264.23M | +76.3% |
| 2021 | $149.91M | +829.0% |
| 2020 | $16.14M | -63.9% |
| 2019 | $44.73M | +121.7% |
| 2018 | $20.18M | -14.1% |
| 2017 | $23.48M | -0.7% |
| 2016 | $23.65M | -49.0% |
| 2015 | $46.36M | - |